On Friday, 3rd February, pharmaphorum travelled to Casa Angelini, Angelini Ventures HQ in Rome – the corporate venture vessel of Angelini Industries – for the inaugural Demo Day
In our final interview from Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sits down with Paolo Borella, who runs the new VITA digital health accelerator in Italy.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh